Hodgkin Lymphoma, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Hodgkin lymphoma provide expert, multidisciplinary recommendations for the diagnosis and treatment of Hodgkin lymphoma. The panel convenes annually to update recommendations based on a review of recently published clinical trials. This selection from the NCCN Guidelines for Hodgkin Lymphoma focuses on the management of newly diagnosed and relapsed/refractory classic Hodgkin lymphoma in adults aged 18 to 60 years.

Authors

Institutions

Publication Details

Journal
Journal of the National Comprehensive Cancer Network
Published
2026-02-01
DOI
https://doi.org/10.6004/jnccn.2026.0006
Primary Topic
Lymphoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Hodgkin Lymphoma, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology

Joanna Chensi Yang, Michael A. Spinner, Dahlia Sano, Sheen Cherian et al.
Journal of the National Comprehensive Cancer Network
Lymphoma Diagnosis and Treatment
article

Hodgkin Lymphoma, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology

Joanna Chensi Yang, Michael A. Spinner, Dahlia Sano, Sheen Cherian, Alex Niu, Justin Paul Kline, Harsh Shah, Weina Chen, Vaishalee Padgaonkar Kenkre, R. Rabinovitch, Alex Francisco Herrera, Ephraim P. Hochberg, Magdalena Czader, Suman Paul, R. Lynch, David A. Bond, L. I. Gordon, Jonathan McConathy, Iris Isufi, J. Svoboda, Sarah Montgomery, C. Kelsey, Zachary AK Frosch, Katie Stehman, David Morgan, Celeste Bello, Cecil M. Benitez, Ali Salavati, Richard T. Hoppe, Jane N. Winter, Neil Hansen, Kara M Kelly, Ranjana H. Advani, Megan E. Daly, Patrick B. Johnston, Bouthaina Dabaja, Philippe Armand, Joachim Yahalom
article en

Abstract

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Hodgkin lymphoma provide expert, multidisciplinary recommendations for the diagnosis and treatment of Hodgkin lymphoma. The panel convenes annually to update recommendations based on a review of recently published clinical trials. This selection from the NCCN Guidelines for Hodgkin Lymphoma focuses on the management of newly diagnosed and relapsed/refractory classic Hodgkin lymphoma in adults aged 18 to 60 years.

Journal of the National Comprehensive Cancer NetworkVol. 24(2)
Fox Chase Cancer Center (US), Roswell Park Comprehensive Cancer Center (US), Barnes-Jewish Hospital (US), City Of Hope National Medical Center (US), Cleveland Clinic (US), Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa (ZA), Memorial Sloan Kettering Cancer Center (US), The University of Texas MD Anderson Cancer Center (US), Breast Cancer Research Foundation (US), University of Utah (US), The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (US), Huntsman Cancer Institute (US), Cancer Institute (WIA) (IN), Susan Thompson Buffett Foundation (US), WinnMed (US), Yale Cancer Center (US), Moffitt Cancer Center (US), Massachusetts General Hospital (US), Fred Hutch Cancer Center (US), Southwestern Medical Center (US), Jewish Hospital (US), University of Wisconsin Carbone Cancer Center (US), Sidney Kimmel Cancer Center (US), University Hospitals Seidman Cancer Center (US), Duke Medical Center (US), University of Colorado Cancer Center (US), Dana-Farber Brigham Cancer Center (US), Smilow Cancer Hospital (US), UCSF Helen Diller Family Comprehensive Cancer Center (US), Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, University of Chicago Medicine Comprehensive Cancer Center, UCLA Jonsson Comprehensive Cancer Center, Vanderbilt-Ingram Cancer Center, Stanford Cancer Institute, Duke Cancer Institute, Fred and Pamela Buffett Cancer Center, UC Davis Comprehensive Cancer Center, Harold C. Simmons Comprehensive Cancer Center, O'Neal Comprehensive Cancer Center, National Comprehensive Cancer Network, Indiana University (US), University of Pennsylvania (US), University of California, Davis (US), The University of Texas Southwestern Medical Center (US), University of Colorado Denver (US)
Good health and well-being
Openalex Percentile: Top 63%
Lymphoma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.